ATE100470T1 - Antibiotische verbindungen, genannt a/16686faktoren a'1,a'2 und a'3. - Google Patents
Antibiotische verbindungen, genannt a/16686faktoren a'1,a'2 und a'3.Info
- Publication number
- ATE100470T1 ATE100470T1 AT88116947T AT88116947T ATE100470T1 AT E100470 T1 ATE100470 T1 AT E100470T1 AT 88116947 T AT88116947 T AT 88116947T AT 88116947 T AT88116947 T AT 88116947T AT E100470 T1 ATE100470 T1 AT E100470T1
- Authority
- AT
- Austria
- Prior art keywords
- antibiotic
- compounds
- atcc
- mutant
- factors
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 230000003115 biocidal effect Effects 0.000 title 1
- YRMCBQLZVBXOSJ-PCFSSPOYSA-N (e)-3-[(6r,6as)-4-hydroxy-6-methoxy-3-methyl-11-oxo-5,6,6a,7-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]prop-2-enamide Chemical compound CO[C@H]1NC2=C(O)C(C)=CC=C2C(=O)N2C=C(\C=C\C(N)=O)C[C@@H]12 YRMCBQLZVBXOSJ-PCFSSPOYSA-N 0.000 abstract 3
- 241000187844 Actinoplanes Species 0.000 abstract 2
- 208000002874 Acne Vulgaris Diseases 0.000 abstract 1
- 241000192125 Firmicutes Species 0.000 abstract 1
- 206010048038 Wound infection Diseases 0.000 abstract 1
- 206010000496 acne Diseases 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000004151 fermentation Effects 0.000 abstract 1
- 238000000855 fermentation Methods 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878727807A GB8727807D0 (en) | 1987-11-27 | 1987-11-27 | Novel antibiotic compounds named a/16686 factors a'1,a'2 and a'3 |
EP88116947A EP0318680B1 (de) | 1987-11-27 | 1988-10-13 | Antibiotische Verbindungen, genannt A/16686-Faktoren A'1,A'2 und A'3 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE100470T1 true ATE100470T1 (de) | 1994-02-15 |
Family
ID=10627634
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT88116947T ATE100470T1 (de) | 1987-11-27 | 1988-10-13 | Antibiotische verbindungen, genannt a/16686faktoren a'1,a'2 und a'3. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0318680B1 (de) |
JP (1) | JPH0791315B2 (de) |
KR (1) | KR890008168A (de) |
AT (1) | ATE100470T1 (de) |
DE (1) | DE3887292T2 (de) |
DK (1) | DK612188A (de) |
ES (1) | ES2061590T3 (de) |
GB (1) | GB8727807D0 (de) |
IE (1) | IE883451L (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3851268T2 (de) * | 1987-06-19 | 1995-01-26 | Sandoz Ag | Zyklische Peptolide. |
DE69019464T2 (de) * | 1989-11-07 | 1995-09-28 | Lepetit Spa | Verfahren zur Rückgewinnung von Antibiotikum A/16686. |
EP0976394A1 (de) * | 1998-07-30 | 2000-02-02 | Biosearch Italia S.p.A. | Neue injizierbare Formulierungen |
US7169890B2 (en) | 2002-03-08 | 2007-01-30 | Vicuron Pharmaceuticals Inc. | Process for the production of ramoplanin-like amide derivatives |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE7031T1 (de) * | 1980-08-16 | 1984-04-15 | Gruppo Lepetit S.P.A. | Antibiotikum a/16686 faktor a2, verfahren zu dessen herstellung und die gleichzeitig hergestellten antibiotika a/16686 faktoren a1 und a3. |
-
1987
- 1987-11-27 GB GB878727807A patent/GB8727807D0/en active Pending
-
1988
- 1988-10-13 EP EP88116947A patent/EP0318680B1/de not_active Expired - Lifetime
- 1988-10-13 ES ES88116947T patent/ES2061590T3/es not_active Expired - Lifetime
- 1988-10-13 AT AT88116947T patent/ATE100470T1/de not_active IP Right Cessation
- 1988-10-13 DE DE88116947T patent/DE3887292T2/de not_active Expired - Fee Related
- 1988-11-03 DK DK612188A patent/DK612188A/da not_active Application Discontinuation
- 1988-11-17 JP JP63289028A patent/JPH0791315B2/ja not_active Expired - Lifetime
- 1988-11-18 IE IE883451A patent/IE883451L/xx unknown
- 1988-11-19 KR KR1019880015288A patent/KR890008168A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPH01168700A (ja) | 1989-07-04 |
ES2061590T3 (es) | 1994-12-16 |
EP0318680B1 (de) | 1994-01-19 |
JPH0791315B2 (ja) | 1995-10-04 |
DK612188D0 (da) | 1988-11-03 |
DE3887292T2 (de) | 1994-05-05 |
EP0318680A2 (de) | 1989-06-07 |
KR890008168A (ko) | 1989-07-10 |
EP0318680A3 (en) | 1990-08-01 |
DK612188A (da) | 1989-05-28 |
IE883451L (en) | 1989-05-27 |
GB8727807D0 (en) | 1987-12-31 |
DE3887292D1 (de) | 1994-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2059725T3 (es) | Antibiotico. | |
IE800697L (en) | Glycopeptide antibiotic a/16686 | |
SE8502135D0 (sv) | 4'-deschlororebeccamycin and process for its preparation | |
ES2010729A6 (es) | Un procedimiento para prerparar un des-acil- antibiotico a 40926. | |
SE8502996D0 (sv) | Antitumor antibiotic compound | |
DE3887292D1 (de) | Antibiotische Verbindungen, genannt A/16686-Faktoren A'1,A'2 und A'3. | |
EP0337203A3 (en) | Aglycons of a/16686 antibiotics | |
DE3781846D1 (de) | Antibiotikum-a-42867 und dessen zusatzsalze. | |
NO911414L (no) | Streptomyces ncimb 40277, biologisk stimulerende preparatinneholdende mikroorganismen, samt anvendelse derav for stimulering av plantevekst og -produksjon. | |
ES2060962T3 (es) | Antibioticos glicopeptidicos. | |
AU551023B2 (en) | Microorganism and antibiotic therefrom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |